Two Sigma Investments, LP Plus Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.3 - $8.4 $3,180 - $89,040	10,600 New	10,600 $3,000
Q1 2022 May 16, 2022	SELL	$0.87 - $1.32 $85,806 - $130,188	-98,628 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.03 - $1.94 $84,708 - $159,547	82,241 Added 501.87%	98,628 $104,000
Q3 2021 Nov 15, 2021	SELL	$1.83 - $2.46 $168,610 - $226,657	-92,137 Reduced 84.9%	16,387 $31,000
Q2 2021 Aug 16, 2021	BUY	$2.0 - $2.89 $217,048 - $313,634	108,524 New	108,524 $278,000
Q1 2021 May 17, 2021	SELL	$2.1 - $3.75 $118,908 - $212,336	-56,623 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.0 - $2.76 $80,298 - $110,811	40,149 Added 243.71%	56,623 $114,000
Q3 2020 Nov 16, 2020	BUY	$2.11 - $3.17 $34,760 - $52,222	16,474 New	16,474 $42,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $46.4M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.